Rivaban Tablet 2.5 mg contains Rivaroxaban, a direct oral anticoagulant (DOAC) that selectively inhibits factor Xa, an essential enzyme in the blood clotting cascade. At this lower dose, Rivaban is often prescribed for long-term prevention of cardiovascular events, including stroke and systemic embolism in patients with atrial fibrillation, or to reduce the risk of recurrent heart-related complications in patients with coronary artery disease (CAD) or peripheral artery disease (PAD). It provides a convenient oral option for patients who require ongoing anticoagulation.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Rivaroxaban 2.5 mg
• Dosage Form: Oral tablet

Indications

Rivaban Tablet 2.5 mg is indicated for:

• Reducing the risk of major cardiovascular events in patients with stable coronary artery disease (CAD) or peripheral artery disease (PAD)
• Prevention of stroke and systemic embolism in non-valvular atrial fibrillation (as part of combination therapy, if recommended)
• Long-term management of patients at risk of thromboembolic events

Mechanism of Action

Rivaroxaban works as a selective factor Xa inhibitor. Factor Xa is a key enzyme that converts prothrombin to thrombin, leading to fibrin clot formation. By inhibiting factor Xa, Rivaban reduces thrombin generation, preventing the formation of harmful blood clots. Its anticoagulant effect is predictable, providing effective protection with a low risk of frequent dose adjustments.

Dosage and Administration

• Recommended dose: 2.5 mg twice daily, or as prescribed by the physician depending on the patient’s condition
• Can be taken with or without food
• Swallow the tablet whole; do not crush, split, or chew
• Adherence to prescribed timing is important for optimal protection against cardiovascular events

Benefits

• Reduces the risk of stroke and systemic embolism in patients with atrial fibrillation
• Lowers the chance of recurrent heart attacks or blood clots in CAD/PAD patients
• Convenient oral therapy without frequent blood monitoring in most patients
• Provides long-term cardiovascular protection with predictable anticoagulant effects

Possible Side Effects

Common side effects may include:

• Minor bleeding (nosebleeds, bruising, or gum bleeding)
• Nausea or mild gastrointestinal discomfort
• Headache or dizziness

Serious side effects are rare but may include severe bleeding or allergic reactions. Seek immediate medical attention if severe bleeding, unusual bruising, or signs of an allergic reaction occur.

Precautions and Warnings

• Avoid use in patients with active bleeding or severe liver impairment
• Caution in patients with kidney problems
• Inform your doctor about other medications, especially anticoagulants or antiplatelet agents
• Not recommended during pregnancy or breastfeeding unless specifically advised
• Keep out of reach of children

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store at room temperature (15°C–30°C)
• Protect from moisture and light
• Keep the bottle tightly closed

Conclusion

Rivaban Tablet 2.5 mg (Rivaroxaban) is a low-dose, effective oral anticoagulant for long-term prevention of cardiovascular events and thromboembolic complications. Its predictable effect, convenient oral dosing, and minimal monitoring requirements make it suitable for patients with CAD, PAD, or atrial fibrillation who require ongoing protection against blood clots.